Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data
Maria Gontika, Charalampos Skarlis, Nikolaos Markoglou, Maria‐Eleftheria Evangelopoulos, Georgios Velonakis, George Chrousos, Marinos C. Dalakas, Leonidas Stefanis, Maria Anagnostouli (2021). Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data. , 43(4), DOI: https://doi.org/10.1007/s10072-021-05623-2.
